Amneal Pharmaceuticals (AMRX) shares outstanding

Shares outstanding · fiscal 2025
324.81M

Amneal Pharmaceuticals (AMRX) had 324.81M diluted shares on average in fiscal 2025 (the year ended December 31, 2025). That is 5.1% higher than the 308.98M of fiscal 2024. Figures as of 18 Nov 2026, 11:49 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Shares outstanding, fiscal 2025
324.81M
Change on fiscal 2024
+5.1%
Growth, 5 years
+16.9% a year
Highest on record
324.81Mfiscal 2025
Lowest on record
127.25Mfiscal 2018
Fiscal years on record
82018–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

Amneal Pharmaceuticals shares outstanding, in more detail

The market data feed counts 348.41M shares outstanding today.

Over the five fiscal years to 2025 the diluted share count grew at a compound 16.9% a year. Across the 8 fiscal years on record (2018–2025), the highest was 324.81M in fiscal 2025 and the lowest 127.25M in fiscal 2018.

History · 8 fiscal years

Shares outstanding by fiscal year

Amneal Pharmaceuticals shares outstanding, year by year

Amneal Pharmaceuticals (AMRX) shares outstanding by fiscal year
Fiscal yearShares outstandingChangeYear ended
2025324.81M 5.1% up
2024308.98M 75.4% up
2023176.14M 16.7% up
2022150.94M 0.6% down
2021151.82M 2.0% up
2020148.91M 12.7% up
2019132.11M 3.8% up
2018127.25M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

The share count for each fiscal year is the diluted weighted average the company reports with its earnings per share, re-based for later stock splits; the number outstanding today comes from the market data feed.

How to read it

A falling count means buybacks are giving each remaining share a larger slice of the company; a rising one means owners are being diluted.

Shares outstanding at health care companies of similar size

Shares outstanding of Amneal Pharmaceuticals and comparable companies
CompanyShares outstandingFiscal year
Cytokinetics CYTK120.10M2025
ABIVAX ABVX69.53M2025
Bausch + Lomb BLCO353.80M2025
Amneal Pharmaceuticals AMRX324.81M2025
Caris Life Sciences CAI167.21M2025
Immunovant IMVT182.42M2026

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on AMRX

Amneal Pharmaceuticals, figure by figure

Amneal Pharmaceuticals (AMRX) overview: price, valuation and scorecardAll health care companies by market value

Amneal Pharmaceuticals shares outstanding: questions and answers

How many shares does Amneal Pharmaceuticals have?

Amneal Pharmaceuticals (AMRX) had 324.81M diluted shares on average in fiscal 2025 (the year ended December 31, 2025). That is 5.1% higher than the 308.98M of fiscal 2024. The market data feed counts 348.41M shares outstanding today.

What is the growth rate of Amneal Pharmaceuticals's diluted share count?

Over the five fiscal years to 2025 the diluted share count grew at a compound 16.9% a year.

What are the highest and lowest diluted share count figures on record for Amneal Pharmaceuticals?

Across the 8 fiscal years on record (2018–2025), the highest was 324.81M in fiscal 2025 and the lowest 127.25M in fiscal 2018.

How is Amneal Pharmaceuticals's diluted share count calculated?

The share count for each fiscal year is the diluted weighted average the company reports with its earnings per share, re-based for later stock splits; the number outstanding today comes from the market data feed. For Amneal Pharmaceuticals it is on record here for 8 fiscal years, 2018 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Amneal Pharmaceuticals (AMRX) shares outstanding”, data as of 18 November 2026. https://funkfolio.com/stock/AMRX/shares-outstanding

Underlying data: the company's filings with the SEC and Yahoo Finance.